UnitedHealth Group (UNH) stock
NYSE
As of the Nov 13, 2026 close (U.S. Eastern)
- Market cap
- $365.1B
- As of Nov 13, 2026
- P/E
- 22.98x
- Trailing twelve months
- P/B
- 3.51x
- Latest reported equity
- P/S
- 0.81x
- Trailing twelve months
- ROE
- 15.3%
- Trailing twelve months
- Dividend yield
- 2.14%
- Latest fiscal-year dividends
Multiples use the price as of Nov 13, 2026 and may differ from the current price.
- Market cap
- $365.1B
- As of Nov 13, 2026
- P/E
- 22.98x
- Trailing twelve months
- P/B
- 3.51x
- Latest reported equity
- P/S
- 0.81x
- Trailing twelve months
- ROE
- 15.3%
- Trailing twelve months
- Dividend yield
- 2.14%
- Latest fiscal-year dividends
Multiples use the price as of Nov 13, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 13, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
22.98x
P/B
3.51x
P/S
0.81x
Earnings and dividend metrics▾
Earnings
EPS
$17.73
Earnings per share
BPS
$116.22
Book value per share
ROE
15.3%
Return on equity
- EPS — what one share earned over the last four quarters. This company earned $17.73 per share.
- BPS — net assets divided by the number of shares. Each share is backed by $116.22 of net assets.
- ROE — how much the company earned on shareholder equity over a year: 15.3%.
Dividends
Yield
2.14%
Dividend per share
$8.73
Payout ratio
49.8%
Consecutive years
19+ yrs
Yield uses fiscal 2025 dividends · Dividend per share and payout ratio are for fiscal 2025.
- Dividend yield — dividends divided by the share price (or market cap). It falls when the price rises.
- Dividend per share — the fiscal-year dividend per share. For one hundred shares that is about $873.00 before tax.
- Payout ratio — 49.8% of earnings was paid out as dividends.
- Consecutive years — dividends were paid every year for more than 19 years. That does not mean they will continue.
Reference only · not a promise of future dividends
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from SEC financial filings: net income and revenue are summed over the latest four quarters, and equity is the latest reported balance.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Latest earnings
SEC filingsJul–Sep 2026(FY2026 Q3)
Revenue decreased 0.4% from the same period a year earlier.
Key reported figures come first. Select one to see the same quarter across three years.
Revenue · same quarter, three years
Year-ago quarter $113.2B-0.4%
$100.8B
Jul–Sep '24
$113.2B
Jul–Sep '25
$112.7B
Jul–Sep '26
The next earnings date has not been confirmed yet.
ⓘ Notes on these figures▾
- Results for Jul–Sep 2026 are from the 10-Q submitted to SEC EDGAR on Nov 3, 2026.
- Earnings per share increased 76.1% from the same quarter a year earlier.
- Revenue decreased 0.4% from the same quarter a year earlier.
- Operating income increased 52.1% from the same quarter a year earlier.
- Net income increased 75.0% from the same quarter a year earlier.
Filed Nov 3, 2026 · 10-Q · SEC EDGAR
Reported results are from SEC EDGAR filings. Reference information only, not investment advice.
Insider transactions
Recent Form 4 filings grouped by person, date and transaction type.
- Noel Timothy JohnChief Executive Officer, UHC · Nov 11, 2026Shares withheld for taxes587 shares · $236KAvg. price $402.9417,148 shares held after
- MCNABB FREDERICK WILLIAM IIIDirector · Oct 1, 2026Grant or award291 shares · $0Avg. price $015,810 shares held after
- Baker Charles D.Director · Oct 1, 2026Grant or award257 shares · $0Avg. price $02,668 shares held after
- FLYNN TIMOTHY PATRICKDirector · Oct 1, 2026Grant or award262 shares · $0Avg. price $011,205 shares held after
- Gil KristenDirector · Oct 1, 2026Grant or award240 shares · $0Avg. price $02,867 shares held after
- GARCIA PAUL RDirector · Oct 1, 2026Grant or award258 shares · $0Avg. price $0
Show 2 price lots
- 155 shares × $0$0
- 103 shares × $0$0
- Gottlieb ScottDirector · Oct 1, 2026Grant or award257 shares · $0Avg. price $0921 shares held after
- MONTGOMERY RICE VALERIE MDDirector · Oct 1, 2026Grant or award257 shares · $0Avg. price $08,180 shares held after
- Noseworthy John HDirector · Oct 1, 2026Grant or award240 shares · $0Avg. price $07,902 shares held after
- MONTGOMERY RICE VALERIE MDDirector · Sep 22, 2026Grant or award47 shares · $0Avg. price $07,923 shares held after
- Stankiewicz Dennis AndrewChief Accounting Officer · Sep 22, 2026Grant or award51 shares · $0Avg. price $010,109 shares held after
- MCNABB FREDERICK WILLIAM IIIDirector · Sep 22, 2026Grant or award57 shares · $0Avg. price $015,519 shares held after
- DeVeydt Wayne SChief Financial Officer · Sep 22, 2026Grant or award106 shares · $0Avg. price $018,676 shares held after
- Gil KristenDirector · Sep 22, 2026Grant or award10 shares · $0Avg. price $02,627 shares held after
- Noseworthy John HDirector · Sep 22, 2026Grant or award46 shares · $0Avg. price $07,662 shares held after
- Baker Charles D.Director · Sep 22, 2026Grant or award15 shares · $0Avg. price $02,411 shares held after
- FLYNN TIMOTHY PATRICKDirector · Sep 22, 2026Grant or award68 shares · $0Avg. price $010,943 shares held after
- Gottlieb ScottDirector · Sep 22, 2026Grant or award5 shares · $0Avg. price $0664 shares held after
- McSweeney ErinEVP & Chief People Officer · Sep 22, 2026Grant or award53 shares · $0Avg. price $015,654 shares held after
- Conway Patrick HughChief Executive Officer, Optum · Sep 22, 2026Grant or award91 shares · $0Avg. price $015,419 shares held after
- GARCIA PAUL RDirector · Sep 22, 2026Grant or award16 shares · $0Avg. price $03,922 shares held after
- HEMSLEY STEPHEN JCEO, UHG · Sep 22, 2026Grant or award50 shares · $0Avg. price $0177,690 shares held after
- Noel Timothy JohnChief Executive Officer, UHC · Sep 22, 2026Grant or award84 shares · $0Avg. price $017,735 shares held after
- Zaetta Christopher REVP & Chief Legal Officer · Sep 22, 2026Grant or award67 shares · $0Avg. price $015,927 shares held after
- DeVeydt Wayne SChief Financial Officer · Sep 2, 2026Shares withheld for taxes1,209 shares · $483KAvg. price $399.6618,570 shares held after
- Conway Patrick HughChief Executive Officer, Optum · Aug 21, 2026Open-market sale1,169 shares · $456KAvg. price $39015,328 shares held after
- Stankiewicz Dennis AndrewChief Accounting Officer · Aug 11, 2026Shares withheld for taxes233 shares · $94KAvg. price $402.1910,058 shares held after
- Conway Patrick HughChief Executive Officer, Optum · Aug 5, 2026Open-market sale500 shares · $205KAvg. price $41016,497 shares held after
Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.
Recent SEC filings
40 filingsRecent filing summaries
Newest first by publication date · may differ from the filing date
- AI summary8-KThe company said its consolidated revenues for Q3 2026 were $112.7 billion ($113.2 billion in the year-ago quarter), earnings from operations were $6.6 billion ($4.3 billion a year earlier), and its net margin was 3.6%.Published Oct 13, 2026 · Filed Oct 13, 2026Read the summary →
- AI summary8-KThe company said that senior executives of UnitedHealth Group will participate in a question-and-answer interview format at the Barclays 28th Annual Global Healthcare Conference on March 10, 2026 Tuesday at 11:30 a.m. Eastern Time.Published Sep 30, 2026 · Filed Mar 9, 2026Read the summary →
- AI summary8-KUnitedHealth Group said on February 24, 2026 the Board of Directors appointed Dennis Stankiewicz, age 48, to the position of Chief Accounting Officer, effective March 2, 2026.Published Oct 4, 2026 · Filed Mar 2, 2026Read the summary →
Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.
Company overview
Expand ▾
UnitedHealth Group (UNH) stock information
NYSE
UnitedHealth Group (UNH) is listed on NYSE. Its market capitalization is about $365.1B. On trailing-twelve-month earnings the P/E ratio is 22.98, and the P/B ratio is 3.51. Return on equity is 15.3%. These figures are computed in-house from official filings and are reference information only.
UnitedHealth Group — frequently asked questions
- What is the P/E ratio of UnitedHealth Group (UNH)?
- On a trailing-twelve-month basis, UNH trades at a P/E ratio of 22.98. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of UnitedHealth Group?
- UNH has a market capitalization of about $365.1B. The figure moves with the share price and is refreshed each trading day.
- Does UnitedHealth Group pay a dividend?
- UNH has a dividend yield of about 2.14%, based on disclosed payment history. Dividend policy can change; this is reference information only.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.